{"schema_version":"secwatch.filing_event.v1","accession":"0000320017-22-000071","form_type":"8-K","ticker":"LSTA","cik":"0000320017","company_name":"LISATA THERAPEUTICS, INC.","filed_at":"2022-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.772352+00:00","generated_at":"2026-06-23T22:38:16.295933+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Caladrius receives Nasdaq extension to Feb 13, 2023 to regain $1 bid price compliance","bullets":["Company failed to meet $1 minimum bid price by Aug 17, 2022 initial compliance deadline.","Nasdaq granted extension to Feb 13, 2023; requires closing bid of $1+ for 10 consecutive days.","If compliance not demonstrated by Feb 13, 2023, delisting notice will be issued.","Company may appeal delisting determination, but success cannot be assured."],"urls":{"canonical":"https://secwatch.observer/filing/0000320017-22-000071","json":"https://secwatch.observer/filing/0000320017-22-000071.json","markdown":"https://secwatch.observer/filing/0000320017-22-000071.md","text":"https://secwatch.observer/filing/0000320017-22-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/320017/000032001722000071/0000320017-22-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/320017/000032001722000071/clbs-20220818.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T22:38:16.295933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}